IL37 and diabetes mellitus: Although the present study does have weaknesses which may be recognized in primary studies of novel entities, to the best of our knowledge, this is one of few studies so far conducted to elucidate the potentially significant role IL-17 and IL-23 could play in diabetes in humans.